OptoLight Vision
Eye Implants for Patients with Retinal Diseases
Health Tech & Life Sciences
Non Active, Aug 2023 ceased to operate
Company Overview
Snapshot
Founded in January 2006 by Isaac Lipshitz and Yariv Lipshitz, OptoLight Vision operates with 1–10 employees. The company ceased operations in August 2023.
Business overview
OptoLight Vision specializes in developing intraocular telescopic eye implants designed to improve the near and distance vision of patients suffering from age-related macular degeneration (AMD) and other retinal diseases. Operating within the Health Tech & Life Sciences sector, specifically Medical Devices and Medical Treatment & Therapeutics, the company serves the healthcare industry by providing solutions for ophthalmology and degenerative eye conditions.
Log in to access full profile ›Company Intelligence Q&A
- What is OptoLight Vision's primary focus?
- OptoLight Vision develops intraocular telescopic eye implants for patients with age-related macular degeneration (AMD) and other retinal diseases, aiming to improve both near and distance vision.
- When was OptoLight Vision founded?
- OptoLight Vision was founded in January 2006.
- What is the operational status of OptoLight Vision?
- OptoLight Vision ceased operations in August 2023.
- Who are the founders of OptoLight Vision?
- OptoLight Vision was co-founded by Isaac Lipshitz and Yariv Lipshitz.
- What products does OptoLight Vision offer?
- OptoLight Vision offers products such as OriLens and LMI, which are intraocular telescopic eye implants.